Andrew Blumenfeld, MD

home / authors / andrew-blumenfeld-md

Articles

Potential Layered Migraine Treatment Approaches to Research: Andrew Blumenfeld, MD

June 17th 2021

The director of the Headache Center of Southern California discussed research opportunities for layered treatment approaches in migraine.

Complexities in Conducting Combination Migraine Therapy Trials: Andrew Blumenfeld, MD

Andrew Blumenfeld, MD

June 13th 2021

The director of the Headache Center of Southern California shared his thoughts on the factors and barriers that go into conducting trials that treat patients with migraine with multiple drugs.

Applying Data on CGRP, OnabotulinumtoxinA Combination to Clinical Practice: Andrew Blumenfeld, MD

Andrew Blumenfeld, MD

June 8th 2021

The director of the Headache Center of Southern California provided insight on how a layered treatment approach to chronic migraine can be directly implemented into clinical care.

Real-World Use of CGRPs in Combination With OnabotulinumtoxinA: Andrew M. Blumenfeld, MD

Andrew Blumenfeld, MD

June 6th 2021

The director of the Headache Center of Southern California discussed his research from AHS 2021 which evaluated safety and efficacy of combined treatment with CGRPs and onabotulimtoxinA.

Andrew Blumenfeld, MD: Long-Term OnabotulimuntoxinA Use in the COMPEL Study

Andrew Blumenfeld, MD

May 20th 2020

The director of the Headache Center of Southern California discussed the findings of the study, as well as what these data might suggest about how onabotulinumtoxinA fits into the shifting landscape of chronic migraine care.